New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
06:39 EDTCLVSClovis price target raised to $100 from $87 at Piper Jaffray
Piper Jaffray raised its price target for Clovis shares to $100 saying the company's clinical development programs are progressing well, with strong enrollment indicated for rociletinib and rucaparib trials. Piper reiterates an Overweight rating on the stock.
News For CLVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 20, 2015
10:00 EDTCLVSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:52 EDTCLVSClovis upgraded to Conviction Buy from Buy at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use